Marketing-authorisation holder · Brazil
Biomm SA
5 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AFREZZA | Insulin (human) | Brazil | Authorised | 2019 |
| BEVYX | Bevacizumab | Brazil | Authorised | 2024 |
| GHEMAXAN | Enoxaparin | Brazil | Authorised | 2020 |
| Glargilin | Insulin glargine | Brazil | Authorised | 2018 |
| RANIVISIO | Ranibizumab | Brazil | Authorised | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 5 | 5 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.